Deutsche Bank Maintains Buy on Gilead Sciences (GILD) after Strong Hepatitis C Combo Data
Go back to Deutsche Bank Maintains Buy on Gilead Sciences (GILD) after Strong Hepatitis C Combo Data| Abbott Laboratories (NYSE: ABT) | Delayed: 90.49 -0.04 (0.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $90.53 | 52 Week High | $46.38 | |||
| Open | $91.19 | 52 Week Low | $36.00 | |||
| Day High | $92.92 | P/E | 60.33 | |||
| Day Low | $90.30 | EPS | $1.50 | |||
| Volume | 13,201,499 | |||||
| Gilead Sciences (NASDAQ: GILD) | Delayed: 125.16 +0.11 (0.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $125.05 | 52 Week High | $108.63 | |||
| Open | $125.56 | 52 Week Low | $71.39 | |||
| Day High | $127.27 | P/E | 69.15 | |||
| Day Low | $124.78 | EPS | $1.81 | |||
| Volume | 7,408,933 | |||||
